EYE 1.35% 18.8¢ nova eye medical limited

CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-389

  1. 16,604 Posts.
    lightbulb Created with Sketch. 4491
    It's not dormant, it's already started spewing dollar signs. Sales have been exploding since early last year when the new device was launched. We're not even speculating that EYE will be a winner anymore, it already is one (in everything but share price).

    80% growth in the most recent half, expecting even higher growth in this half given the significant investment in expanding the marketing effort.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.